Teva Pharma (TEVA) Tops Q1 EPS by 4c; offers guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) | Delayed: 41.83 -0.08 (0.19%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $41.91 | 52 Week High | $66.55 | |||
| Open | $41.89 | 52 Week Low | $37.82 | |||
| Day High | $42.02 | P/E | N/A | |||
| Day Low | $41.29 | EPS | $0.00 | |||
| Volume | 1,792,620 | |||||
